(Q48606060)

13 February 2018

title

IDH1 mutation in pediatric gliomas: has it a diagnostic and prognostic value? (English)

1 reference

13 February 2018

author

Lorenzo Genitori

5

1 reference

13 February 2018

author name string

Anna Maria Buccoliero

1

1 reference

13 February 2018

Francesca Castiglione

2

1 reference

13 February 2018

Duccio Rossi Degl'Innocenti

3

1 reference

13 February 2018

Chiara Francesca Gheri

4

1 reference

13 February 2018

Gian Luigi Taddei

6

1 reference

13 February 2018

publication date

20 March 2012

1 reference

13 February 2018

Fetal and Pediatric Pathology

published in

1 reference

13 February 2018

volume

31

1 reference

13 February 2018

issue

5

1 reference

13 February 2018

page(s)

278-282

1 reference

13 February 2018

An integrated genomic analysis of human glioblastoma multiforme

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15513815.2012.659383

Glioma IDH1 mutation patterns off the beaten track.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15513815.2012.659383

Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15513815.2012.659383

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15513815.2012.659383

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15513815.2012.659383

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15513815.2012.659383

Mutant metabolic enzymes are at the origin of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15513815.2012.659383

IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15513815.2012.659383

Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15513815.2012.659383

IDH1 and IDH2 mutations in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15513815.2012.659383

Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15513815.2012.659383

Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15513815.2012.659383

10.3109/15513815.2012.659383

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018